These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15151824)
1. [Effects of anti-HPV16 E6-ribozyme on invasiveness of cervical carcinoma cell line CaSKi and vascular endothelial growth factor expression]. Liu K; Wang LL; Zheng YF; Zhang JR Di Yi Jun Yi Da Xue Xue Bao; 2004 May; 24(5):529-32. PubMed ID: 15151824 [TBL] [Abstract][Full Text] [Related]
2. [Effect of anti-HPV16 E6-ribozyme on cell proliferation and invasiveness of cervical carcinoma cell line CaSKi]. Liu K; Wang LL; Sun F; Zheng YF; Zhang JR Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1367-72. PubMed ID: 15604060 [TBL] [Abstract][Full Text] [Related]
3. [Radiation sensitizing effect of anti HPV16E6-ribozyme on cervical carcinoma cell line]. Rao ZG; Zhang JR; Zheng YF; Zhou H; Qu LH Ai Zheng; 2002 Feb; 21(2):149-52. PubMed ID: 12479064 [TBL] [Abstract][Full Text] [Related]
4. Effects of anti-HPV16 E6-ribozyme on the proliferation and apoptosis of human cervical cancer cell line CaSKi. Zheng YF; Rao ZG; Zhang JR Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun; 22(6):496-8. PubMed ID: 12297466 [TBL] [Abstract][Full Text] [Related]
5. Effects of anti-HPV16E6-ribozyme on phenotype and gene expression of a cervical cancer cell line. Zheng Y; Zhang J; Qu L Chin Med J (Engl); 2002 Oct; 115(10):1501-6. PubMed ID: 12490096 [TBL] [Abstract][Full Text] [Related]
6. Ribozyme targeted on HPV16E6 mRNA induced apoptosis on human cervical carcinoma CaSKi cells. Zheng YF; Zhang JR Ai Zheng; 2003 May; 22(5):458-62. PubMed ID: 12753702 [TBL] [Abstract][Full Text] [Related]
7. [Effect of anti-HPV16 E6-ribozyme on the sensitivity of cervical carcinoma cell line to chemotherapy]. Rao ZG; Zhang JR; Zheng YF; Zhou H; Qu LG Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):316-9. PubMed ID: 12390732 [TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effect of RNA interference on expression of HPV16 E6 oncogene in cervical cancer cell line CaSki]. Niu XY; Peng ZL; Wang H Ai Zheng; 2004 Nov; 23(11):1257-62. PubMed ID: 15522169 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers. Mathur RS; Mathur SP Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460 [TBL] [Abstract][Full Text] [Related]
11. [Effect of siRNA inhibiting HPV16 E6 gene expression on proliferation and cell cycle of cervical cancer cell line CaSki]. Guan LL; Peng ZL; Niu XY; Wang HJ; Wang DQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):10-4. PubMed ID: 18390189 [TBL] [Abstract][Full Text] [Related]
12. [Inhibition of HPV16 E6 oncogene in cervical cancer by RNA interference]. Niu XY; Peng ZL; Duan WQ; Wang H; Chen YY; Fan YJ; Cheng YF; Qian XL Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):14-8. PubMed ID: 16468632 [TBL] [Abstract][Full Text] [Related]
13. [Inhibiting effect of HPV16 E6 small interfering RNA on the growth of human cervical carcinoma xenotransplanted in nude mice]. Guan LL; Peng ZL; Niu XY Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):894-7. PubMed ID: 18478926 [TBL] [Abstract][Full Text] [Related]
14. [Reversal effect of antisense RNA targeting human papillomavirus 16 (HPV16) E6E7 on malignancy of human cervical cancer cell line SiHa]. Sima N; Wang W; Xu Q; Tian X; Luo AY; Lu YP; Wang SX; Ma D Ai Zheng; 2007 Jan; 26(1):26-31. PubMed ID: 17222363 [TBL] [Abstract][Full Text] [Related]
15. [Experimental study of anti-VEGF hairpin ribozyme gene inhibiting expression of VEGF and proliferation of ovarian cancer cells]. Yan RL; Qian XH; Xin XY; Jin M; Hui HX; Wang DT; Wang J Ai Zheng; 2002 Jan; 21(1):39-44. PubMed ID: 12500395 [TBL] [Abstract][Full Text] [Related]
16. [Experimental study of anti-vascular endothelial growth factor hairpin ribozyme gene inhibiting growth of xenografted tumor of ovarian cancer cells]. Yan R; Xin X; Jin M; Hui H; Wang J; Wang D Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):683-6. PubMed ID: 12487926 [TBL] [Abstract][Full Text] [Related]
17. [Effects of human papillomavirus 16 E5 on malignancy of human cervical cancer cells and the mechanism there of]. Liao SJ; Deng DR; Xia X Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(43):3080-4. PubMed ID: 19192411 [TBL] [Abstract][Full Text] [Related]
18. Reversal of the malignant phenotype of cervical cancer CaSki cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA. Wu S; Meng L; Wang S; Wang W; Xi L; Tian X; Chen G; Wu Y; Zhou J; Xu G; Lu Y; Ma D Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2032-7. PubMed ID: 16609012 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines. Lane D; Gray EA; Mathur RS; Mathur SP Am J Reprod Immunol; 2005 Mar; 53(3):153-8. PubMed ID: 15727570 [TBL] [Abstract][Full Text] [Related]
20. Selective targeting of HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo. Wang W; Sima N; Kong D; Luo A; Gao Q; Liao S; Li W; Han L; Wang J; Wang S; Lu Y; Wang D; Xu G; Zhou J; Meng L; Ma D Cancer Lett; 2010 May; 291(1):67-75. PubMed ID: 19903581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]